The bivalent mRNA boosters from Pfizer-BioNTech and Moderna were 48% effective against symptomatic infection from the predominant omicron subvariant (XBB/XBB.1.5) in persons aged 18-49 years according to early data published by the CDC nbcnews.com Submitted by shiruken t3_10lcgah on January 25, 2023 at 10:58 PM in science 75 comments 337
Don_Ford t1_j5xrz3i wrote on January 26, 2023 at 8:04 AM This is like playing with toys when we have Novavax that is still working and at a much higher level. Permalink −6− ShelZuuz t1_j5y0w1d wrote on January 26, 2023 at 10:08 AM So where is the Novavax studies against XBB1.5? Permalink Parent 13 [deleted] t1_j5xuplf wrote on January 26, 2023 at 8:41 AM [removed] Permalink Parent 1
ShelZuuz t1_j5y0w1d wrote on January 26, 2023 at 10:08 AM So where is the Novavax studies against XBB1.5? Permalink Parent 13
Viewing a single comment thread. View all comments